期刊文献+

胃癌患者CD4^+CD25^+Foxp3^+调节性T淋巴细胞数量和分布的研究 被引量:5

Study on number and distribution of CD4^+CD25^+Foxp3^+ regulatory T lymphocyte in patients with gastric cancer
下载PDF
导出
摘要 目的分析CD4+CD25+Foxp3+调节性T淋巴细胞(Treg)数量和分布的相关性,研究两者之间的相关性。方法选取该院60例胃癌患者,用流式细胞仪分析患者术前外周血与肿瘤浸润淋巴细胞(TIL)中Treg以及CD8+T细胞的比率。另选出10例胃癌患者分别于手术前、后用ELISA检测血清和腹腔冲洗液中细胞因子的水平,并进行对比分析。结果胃癌患者外周血分析CD4+CD25+Foxp3+Treg显著高于健康对照组,癌症早期患者低于晚期患者(P<0.05);胃癌患者血清比例低于健康对照组(P<0.05)。肿瘤组织浸润淋巴细胞中CD4+CD25+Foxp3+Treg的比率与CD8+T细胞的比率呈负相关(r=-0.4,P<0.05)。10例患者肿瘤切除后CD4+CD25+Foxp3+Treg的比率显著降低(P<0.01)。结论胃癌患者外周血中的CD4+CD25+Foxp3+Treg明显比CD8+T细胞高很多,发展速度极快,经分析研究,CD4+CD25+Foxp3+Treg比率的增高与CD8+T细胞的降低,可能与癌细胞自身的免疫力有着密切关系。 Objective To analyze CD4+CD25+Foxp3+regulatory T(Treg)lymphocyte numbers and distribution,to study the relationship between the two.Methods 60patients with gastric cancer in the hospital were enrolled in the study,the multi-parameter flow cytometry analysis were applied for the Treg and CD8+ T cell ratio in the peripheral blood and tumor infiltrating lymphocytes(TIL)for preoperative patients.10patients with gastric cancer were recruited and had ELISA detection of IFN-γ,IL-4cytokines extent and comparative analysis before and after operation.Results The patients with gastric analysis of CD4+ CD25+ Foxp3+regulatory T lymphocytes was significantly higher than the healthy control group,lower than that of patients with advanced disease(P0.05).For patients with early cancer,proportion of patients with gastric cancer serum Th1/Th2was lower than the healthy control group,the difference was statistically significant(P0.05).Tumor infiltrating lymphocytes CD4+ CD25+Foxp3+ regulatory T lymphocyte ratio and CD8+ T cell ratio was negatively correlated(r=-0.4,P0.05).10patients after removal of tumor,CD4+ CD25+Foxp3+regulatory T lymphocytes ratio was significantly reduced,there were differences with statistically significant(P0.01).Conclusion patients with gastric cancer in peripheral blood CD4+ CD25+Foxp3+regulatory T lymphocytes was significantly higher than that CD8+T cells,and the fast progress analysis study,CD4+CD25+Foxp3+regulatory T lymphocyte ratio increased and CD8+ T cells reduced,probably has a close relationship with the cancer cell's own immune system.
作者 郄燕
出处 《国际检验医学杂志》 CAS 2013年第5期545-547,共3页 International Journal of Laboratory Medicine
关键词 胃肿瘤 T淋巴细胞 调节性 流式细胞术 细胞因子类 stomach neoplasms T-Lymphocytes regulatory flow cytometry cytokines
  • 相关文献

参考文献11

二级参考文献97

  • 1王凌云,黄开红,闵军,苏红,朱兆华.胃癌患者外周血调节性T细胞的多种细胞因子水平的检测及其意义[J].中华实验外科杂志,2006,23(11):1375-1377. 被引量:18
  • 2刘海,郑维,李远明,杨文龙.大肠癌患者外周血调节性T细胞的检测及临床意义[J].中华实验外科杂志,2007,24(5):626-627. 被引量:11
  • 3Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol, 2003,3:189-198.
  • 4Ichihara F, Kono K, Takahashi A, et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patient with gastric and esophageal cancers. Clin Cancer Res, 2003,9:4404-4408.
  • 5Sasada T, Kimura M, Yashida Y, et al. CD4^+ CD25^+ regulatory T cells in patients with gastrointestinal malignancies- Possible involvement of regulatory T cells in disease progression. Cancer, 2003,98 : 1089-1099.
  • 6Hori S, Nomura T, Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3. Science, 2003, 299:1057-1061.
  • 7Wolf M, Wolf D, Steurer M, et al. Increase of regulatory T cell in the peripheral blood of cancer patients. Clin Cancer Res, 2003, 9:606-612.
  • 8Cao D, Malmstrom V, Baecher-Allan C, et al. Isolation and functional characterization of regulatory CD25^bright CD4 ^+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol, 2003,33:215-223.
  • 9Baecher-Allan C, Brown JA, Freeman GJ, et al. CD4^+CD25^high regulatory cells in human peripheral blood. J Immunol, 2001, 167:1245-1253.
  • 10von Herrath MG, Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol, 2003,3:223-232.

共引文献27

同被引文献66

  • 1Li L, Chao QG, Ping LZ, et al. The prevalence of FOXP3^+ regulatory T-cells in peripheral blood of pa- tients with NSCLC. Cancer Biother Radiopharm, 2009, 24: 357-367.
  • 2Sasada T, Kimura M, Yoshida Y, et al. CD4^+CD25^+ r- egulatory T cells in patients with gastrointestinal malig- nancies: possible involvement of regulatory T cells in disease progression. Cancer, 2003, 98: 1089-1099.
  • 3SeoN, Hayakawa S, TakigawaM, et al. Interleukin-10 express atearly tumor sites induces subsequentgeneration of CD4^+ T regulatory cells and systemic collapes of an- titumour immunity. Immunology, 2001, 103: 449-457.
  • 4Strauss L, Bergmann C, Szczepanski M, et al. A uni- que subset of CD4^+CD25highFoxp3^+ T cells secreting interleukin-10 and trans-forming growth factor-betal mediates suppression in the tumor microenvironment. Clin Cancer Res, 2007, 13: 4345-4354.
  • 5Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299: 1057-1061.
  • 6Kryczek I, Wei S, Zou L, et al. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol, 2007, 178: 6730-6733.
  • 7Shevach EM. Mechanisms of foxp3^+ T regulatory cell- mediated suppression. Immunity, 2009, 30: 636-645.
  • 8Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3^+ regulatory T cell function. Science, 2008, 322: 271-275.
  • 9Zhou S, Tao H, Zhen Z, et al. Depletion of CD4^+ CD25^+ Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity. PLoS One, 2013, 8: e73952.
  • 10Reginato E, Mroz P, Chung H, et al. Photodynamic therapy plus regulatory T-cell depletion produces immu- nity against a mouse tumour that expresses a self-anti- gen. Br J Cancer, 2013.[Epub ahead of print].

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部